CAR-T cells - Chinese PLA General Hospital
Blincyto (blinatumomab) - Astellas, Amgen
Besponsa (inotuzumab ozogamicin) - Pfizer
Yorwida (inaticabtagene autoleucel) - CASI
Actemra IV (tocilizumab) - Roche, JW Pharma
https://ashpublications.org/blood/article/146/Supplement%201/6855/554365/Efficacy-and-safety-profile-of-inaticabtagene
 
Bailin He 1; JIN WANG 2; Er-Lie Jiang 3; Yuhua Li 4; Suning Chen 5; Heng Mei 6; Ying Wang 3; Jianmin Yang 7; Jie Jin 8; Ji Xu 9; Meng Lv 10; Jianxiang Wang 3; Shengli Xue 5; Aibin Liang 11; Li Wang 12; Mingzhi Zhang 13; Xudong Wei 14; Zhenyang Gu 15; Fei Li 16; Chong Wang 13; Peng Zhao 17; Xin Du 18; Xianmin Song 19; Yingchang Mi 3; Hongsheng Zhou 1
 
Dec 5, 2025
 
Prev Next